870 related articles for article (PubMed ID: 18714059)
1. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
Ebbing M; Bleie Ø; Ueland PM; Nordrehaug JE; Nilsen DW; Vollset SE; Refsum H; Pedersen EK; Nygård O
JAMA; 2008 Aug; 300(7):795-804. PubMed ID: 18714059
[TBL] [Abstract][Full Text] [Related]
2. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
[TBL] [Abstract][Full Text] [Related]
3. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
Toole JF; Malinow MR; Chambless LE; Spence JD; Pettigrew LC; Howard VJ; Sides EG; Wang CH; Stampfer M
JAMA; 2004 Feb; 291(5):565-75. PubMed ID: 14762035
[TBL] [Abstract][Full Text] [Related]
4. Cancer incidence and mortality after treatment with folic acid and vitamin B12.
Ebbing M; Bønaa KH; Nygård O; Arnesen E; Ueland PM; Nordrehaug JE; Rasmussen K; Njølstad I; Refsum H; Nilsen DW; Tverdal A; Meyer K; Vollset SE
JAMA; 2009 Nov; 302(19):2119-26. PubMed ID: 19920236
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine-lowering B vitamins do not lower mortality or cardiovascular events.
Lundberg GD
Medscape J Med; 2008; 10(12):273. PubMed ID: 19242579
[No Abstract] [Full Text] [Related]
6. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
Albert CM; Cook NR; Gaziano JM; Zaharris E; MacFadyen J; Danielson E; Buring JE; Manson JE
JAMA; 2008 May; 299(17):2027-36. PubMed ID: 18460663
[TBL] [Abstract][Full Text] [Related]
7. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy.
Løland KH; Bleie O; Blix AJ; Strand E; Ueland PM; Refsum H; Ebbing M; Nordrehaug JE; Nygård O
Am J Cardiol; 2010 Jun; 105(11):1577-84. PubMed ID: 20494665
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine lowering and cardiovascular events after acute myocardial infarction.
Bønaa KH; Njølstad I; Ueland PM; Schirmer H; Tverdal A; Steigen T; Wang H; Nordrehaug JE; Arnesen E; Rasmussen K;
N Engl J Med; 2006 Apr; 354(15):1578-88. PubMed ID: 16531614
[TBL] [Abstract][Full Text] [Related]
9. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial.
Schnyder G; Roffi M; Flammer Y; Pin R; Hess OM
JAMA; 2002 Aug; 288(8):973-9. PubMed ID: 12190367
[TBL] [Abstract][Full Text] [Related]
10. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.
Aisen PS; Schneider LS; Sano M; Diaz-Arrastia R; van Dyck CH; Weiner MF; Bottiglieri T; Jin S; Stokes KT; Thomas RG; Thal LJ;
JAMA; 2008 Oct; 300(15):1774-83. PubMed ID: 18854539
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine lowering with folic acid and B vitamins in vascular disease.
Lonn E; Yusuf S; Arnold MJ; Sheridan P; Pogue J; Micks M; McQueen MJ; Probstfield J; Fodor G; Held C; Genest J;
N Engl J Med; 2006 Apr; 354(15):1567-77. PubMed ID: 16531613
[TBL] [Abstract][Full Text] [Related]
13. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
; Armitage JM; Bowman L; Clarke RJ; Wallendszus K; Bulbulia R; Rahimi K; Haynes R; Parish S; Sleight P; Peto R; Collins R
JAMA; 2010 Jun; 303(24):2486-94. PubMed ID: 20571015
[TBL] [Abstract][Full Text] [Related]
14. The China Stroke Secondary Prevention Trial (CSSPT) protocol: a double-blinded, randomized, controlled trial of combined folic acid and B vitamins for secondary prevention of stroke.
Liu X; Shi M; Xia F; Han J; Liu Z; Wang B; Yang F; Li L; Wu S; Wang L; Liu N; Lv Y; Zhao G
Int J Stroke; 2015 Feb; 10(2):264-8. PubMed ID: 23490255
[TBL] [Abstract][Full Text] [Related]
15. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
de Jager CA; Oulhaj A; Jacoby R; Refsum H; Smith AD
Int J Geriatr Psychiatry; 2012 Jun; 27(6):592-600. PubMed ID: 21780182
[TBL] [Abstract][Full Text] [Related]
16. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.
Lee BJ; Huang MC; Chung LJ; Cheng CH; Lin KL; Su KH; Huang YC
Eur J Clin Nutr; 2004 Mar; 58(3):481-7. PubMed ID: 14985687
[TBL] [Abstract][Full Text] [Related]
17. Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.
Lonn E; Held C; Arnold JM; Probstfield J; McQueen M; Micks M; Pogue J; Sheridan P; Bosch J; Genest J; Yusuf S;
Can J Cardiol; 2006 Jan; 22(1):47-53. PubMed ID: 16450017
[TBL] [Abstract][Full Text] [Related]
18. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial.
Heinz J; Kropf S; Domröse U; Westphal S; Borucki K; Luley C; Neumann KH; Dierkes J
Circulation; 2010 Mar; 121(12):1432-8. PubMed ID: 20231532
[TBL] [Abstract][Full Text] [Related]
19. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials.
Ebbing M; Bønaa KH; Arnesen E; Ueland PM; Nordrehaug JE; Rasmussen K; Njølstad I; Nilsen DW; Refsum H; Tverdal A; Vollset SE; Schirmer H; Bleie Ø; Steigen T; Midttun Ø; Fredriksen A; Pedersen ER; Nygård O
J Intern Med; 2010 Oct; 268(4):367-82. PubMed ID: 20698927
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine-lowering interventions for preventing cardiovascular events.
Martí-Carvajal AJ; Solà I; Lathyris D; Dayer M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006612. PubMed ID: 28816346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
